Ultime notizie per Equifax (NYSE:EFX) Azioni

EQUIFAX INC

Equifax

Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.

<a href="https://x.com/pulte/status/1942665475516674342" title="https://x.com/pulte/status/1942665475516674342">https://x.com/pulte/status/1942665475516674342</a>

News

FICO

U.S. Director of Federal Housing Pulte Posts On X "We will be incentivizing lenders, who USE both Vantage 4.0 and FICO, with better pricing - anything to help the consumer."

<a href="https://x.com/pulte/status/1942589271702962447" title="https://x.com/pulte/status/1942589271702962447">https://x.com/pulte/status/1942589271702962447</a>

FMCC

FNMA

U.S. Director of Federal Housing Pulte Posts On X "Effective today, to increase competition to the Credit Score Ecosystem and consistent with President Trump's landslide mandate to lower costs, Fannie and Freddie will ALLOW lenders to use Vantage 4.0 Score with no current requirement to build new infrastructure (stays Tri Merge)."

Wells Fargo analyst Jason Haas maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Overweight and raises the price target from $306 to $310.

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Equifax, Raises Price Target to $310

WIIM

Shares of credit bureau companies are trading lower after U.S. Director of Federal Housing FHFA Bill Pulte said "We are doing a full scale review of all credit bureaus."

<a href="https://x.com/pulte/status/1938659666885779503" rel="noopener noreferrer" target="_blank">https://x.com/pulte/status/1938659666885779503</a>
&nbsp;
<a href="https://x.com/pulte/status/1938659896024551438" title="https://x.com/pulte/status/1938659896024551438">https://x.com/pulte/status/1938659896024551438</a>

Politics

General

U.S. Director of Federal Housing FHFA Bill Pulte Posts On X "We are doing a full scale review of all credit bureaus.", On High Interest Rates Says "It's not just people's mortgages. It's car loans, credit cards, etc. These decisions have real impacts on real people."

Bank of America Securities (BofA) on Monday downgraded Equifax, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) underwhelmed by the company&#8217;s investor day that happened last week.
The company has outlined <a target="_blank" href="https://d1io3yog0oux5.cloudfront.net/_81b29681d02e99ff26eb448c77aba18e/equifax/db/1982/19522/presentation/Investor+Day+2025+Presentation.pdf" rel="noreferrer noopener">its</a> long-term financial framework, projecting an 8%-12% revenue growth rate, with 7%-10% of that being organic and mergers and acquisitions (M&amp;A) contributing roughly 1%-2%.
The company also anticipates cash EPS growth of 12%-16% and an annual shareholder return of 13%-18%.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/46033525/equifax-doubles-down-on-growth-plan-despite-mortgage-market-woes" rel="noreferrer noopener">Equifax Doubles Down On Growth Plan Despite Mortgage Market Woes</a>
During its first-quarter earnings release, Equifax guided fiscal 2025 revenues between $5.91 billion and $6.03 billion, versus a consensus of $5.96 billion and prior guidance of <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">$5.89 billion to $6.01 billion</a>.
The company expected adjusted earnings of $7.25-$7.65 per share versus consensus of $7.48.
Equifax <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/n44917577/equifax-delivers-above-guidance-first-quarter-results-authorizes-new-3-billion-share-repurchase-pr" rel="noreferrer noopener">sees second-quarter sales</a> of $1.49 billion-$1.53 billion compared to the consensus of $1.5 billion and adjusted EPS of $1.85-$1.95 versus the consensus of $1.89.
Analyst Joshua Dennerlein reduced the company&#8217;s 2025 adjusted EPS estimates to $7.58 from $7.63 and its 2026 estimates to $8.91 from $9.22, reflecting tempered growth expectations.
The analyst wrote, &#8220;We were disappointed that EFX did not revise its long-term growth outlook. The long-term framework was originally provided at its 2021 investor day. EFX underperformed these targets given delays in the cloud platform migration &amp; the mortgage market slowdown.&#8221;
BofA downgraded the company from Buy to Neutral, lowering its <a target="_blank" href="https://www.benzinga.com/quote/EFX/analyst-ratings" rel="noreferrer noopener">price forecast to $285 from $300</a>.
BofA Securities cited three key factors for downgrading the stock. The primary concern is that Equifax&#8217;s transformation to a cloud-native platform does not represent a long-term competitive moat for the company.
BofA noted that Equifax&#8217;s future growth would instead depend on product innovation leveraging its unique data assets, which the company expects will drive growth back to its unrevised long-term outlook.
BofA Securities also highlighted that a mortgage market recovery would be the &#8220;real kicker&#8221; to Equifax&#8217;s growth prospects, but the timing is highly uncertain.
Price Action: EFX stock is trading lower by 1.65% to $251.47 at last check Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/sector-etfs/25/02/43637114/regulatory-freeze-at-cfpb-these-etfs-could-gain-as-oversight-weakens" target="_blank" rel="noreferrer noopener">Regulatory Freeze At CFPB: These ETFs Could Gain As Oversight Weakens</a></li>
</ul>
Image via Shutterstock

Analyst Color

Downgrades

Trading Ideas

Equifax's Cloud Not A Moat, Analyst Says In Downgrade Slashing Estimates

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>B of A Securities lowered Equifax Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) price target from $300 to $285. B of A Securities analyst Heather Balsky downgraded the stock from Buy to Neutral. Equifax shares closed at $255.70 on Friday. <a href="https://www.benzinga.com/quote/EFX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JMP Securities increased the price target for Exelixis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NASDAQ">EXEL</a>) from $47 to $50. JMP Securities analyst Silvan Tuerkcan maintained a Market Outperform rating. Exelixis shares closed at $40.37 on Friday. <a href="https://www.benzinga.com/quote/EXEL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Keybanc raised Darden Restaurants, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) price target from $230 to $245. Keybanc analyst Eric Gonzalez maintained an Overweight rating. Darden shares closed at $225.78 on Friday. <a href="https://www.benzinga.com/quote/DRI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BMO Capital slashed the price target for Dow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>) from $29 to $22. BMO Capital analyst John McNulty downgraded the stock from Market Perform to Underperform. Dow shares closed at $27.76 on Friday. <a href="https://www.benzinga.com/quote/DOW/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird raised the price target for Couchbase, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BASE#NASDAQ">BASE</a>) from $22 to $25. Baird analyst Rob Oliver downgraded the stock from Outperform to Neutral. Couchbase shares closed at $24.49 on Friday. <a href="https://www.benzinga.com/quote/BASE/analyst-ratings">See how other analysts view this stock.</a></li>
<li>HC Wainwright &amp; Co. increased FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) price target from $3 to $8. HC Wainwright &amp; Co. analyst Raghuram Selvaraju maintained a Buy rating. FMC shares settled at $41.07 on Friday. <a href="https://www.benzinga.com/quote/FMC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Telsey Advisory Group raised The Kroger Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) price target from $73 to $82. Telsey Advisory Group analyst Joseph Feldman maintained an Outperform rating. Kroger shares closed at $71.97 on Friday. <a href="https://www.benzinga.com/quote/KR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Deutsche Bank increased Compass Minerals International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMP#NYSE">CMP</a>) price target from $14 to $22. Deutsche Bank analyst David Begleiter maintained a Buy rating. Compass Minerals shares closed at $19.38 on Friday.  <a href="https://www.benzinga.com/quote/CMP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo raised the price target for Corteva, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTVA#NYSE">CTVA</a>) from $79 to $82. Wells Fargo analyst Richard Garchitorena maintained an Overweight rating. Corteva shares settled at $73.72 on Friday. <a href="https://www.benzinga.com/quote/CTVA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Melius Research increased Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) price target from $110 to $175. Melius Research analyst Ben Reitzes upgraded the stock from Hold to Buy. AMD shares closed at $128.24 on Friday. <a href="https://www.benzinga.com/quote/AMD/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying AMD stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/AMD/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="609" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/23095218/image-334-1024x609.png" alt="" class="wp-image-958196" style="width:632px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/23095218/image-334-1024x609.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/23095218/image-334-300x178.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/23095218/image-334-768x457.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/23095218/image-334.png 1118w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46023851/top-2-tech-stocks-that-could-sink-your-portfolio-in-june">Top 2 Tech Stocks That Could Sink Your Portfolio In June</a> </li>
</ul>
Photo via Shutterstock

Markets

BASE

CTVA

EXEL

AMD To Rally More Than 36%? Here Are 10 Top Analyst Forecasts For Monday

B of A Securities analyst Heather Balsky downgrades Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) from Buy to Neutral and lowers the price target from $300 to $285.

B of A Securities Downgrades Equifax to Neutral, Lowers Price Target to $285

Equifax Inc's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) latest Investor Day event increased confidence in the company being able to achieve its 2025 and long-term guidance "by focusing on efficient growth despite a choppy mortgage market," according to Needham.
The Equifax Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5f22a54029cf490001b01b94/kyle-peterson">Analyst Kyle Peterson</a> maintained a Buy rating and price target of $295.
The Equifax Thesis: The company reaffirmed its full-year guidance for organic revenue growth of 5%–7.1% for FXN and earnings of $7.45 per share at the midpoint, Peterson said in the note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Equifax also reiterated its long-term targets of 8%–12% revenue growth run rate, with 7%–10% organic revenue growth, he added.
"The company plans to invest ~$1B annually in CapEx/M&amp;A, while returning an additional ~$1B per year to shareholders through dividends and buybacks," the analyst wrote.
Importantly, these targets do not consider any recovery in the mortgage market, "which would be a $1.2B revenue opportunity" when trends begin normalizing.
EFX Price Action: Shares of Equifax had risen by 0.74% to $255.26 at the time of publication on Friday.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/insights/analyst-ratings/25/06/45946624/canaan-stock-a-deep-dive-into-analyst-perspectives-8-ratings">3 Stocks Just Announced Intentions to Buyback Near 10% of Shares</a></li>
</ul>
Image: Shutterstock

Reiteration

Equifax Doubles Down On Growth Plan Despite Mortgage Market Woes

Needham analyst Mayank Tandon reiterates Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Buy and maintains $295 price target.

Needham Reiterates Buy on Equifax, Maintains $295 Price Target

Stifel analyst Shlomo Rosenbaum maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Buy and raises the price target from $277 to $295.

Stifel Maintains Buy on Equifax, Raises Price Target to $295

RBC Capital analyst Ashish Sabadra reiterates Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Outperform and maintains $300 price target.

RBC Capital Reiterates Outperform on Equifax, Maintains $300 Price Target

Across the recent three months, 7 analysts have shared their insights on Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $292.29, a high estimate of $306.00, and a low estimate of $260.00. A 2.24% drop is evident in the current average compared to the previous average price target of $299.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1749564048_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A comprehensive examination of how financial experts perceive Equifax is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Toni Kaplan</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$305.00</td>
<td>$295.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$296.00</td>
<td>$277.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$306.00</td>
<td>$288.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$300.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Kyle Peterson</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$295.00</td>
<td>$295.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$284.00</td>
<td>$313.00</td>
</tr>
<tr>
<td>Manav Patnaik</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$260.00</td>
<td>$325.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Equifax. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Equifax compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Equifax's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Equifax's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/EFX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Equifax analyst ratings.</a>
<h2>Discovering Equifax: A Closer Look</h2>
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.
<h3>Understanding the Numbers: Equifax's Finances</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Equifax's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 3.79%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: Equifax's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 9.23% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Equifax's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 2.72%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Equifax's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 1.13%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Equifax's debt-to-equity ratio is below the industry average. With a ratio of 1.0, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Equifax's Future

Morgan Stanley analyst Toni Kaplan maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Overweight and raises the price target from $295 to $305.

Morgan Stanley Maintains Overweight on Equifax, Raises Price Target to $305

<a href="https://x.com/pulte/status/1930323713154789718">https://x.com/pulte/status/1930323713154789718</a>

U.S. Director Of Federal Housing FHFA Pulte Posts On X "I am meeting with the Equifax CEO today, it should be an interesting meeting. I also had a great meeting with the National Association of Realtors and much more"

Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) has outperformed the market over the past 15 years by 3.84% on an annualized basis producing an average annual return of 15.61%. Currently, Equifax has a market capitalization of $32.56 billion. 
Buying $1000 In EFX: If an investor had bought $1000 of EFX stock 15 years ago, it would be worth $8,787.80 today based on a price of $262.14 for EFX at the time of writing.
<h3>Equifax's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748464221_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

<a href="https://www.cnbc.com/live-tv/" title="https://www.cnbc.com/live-tv/">https://www.cnbc.com/live-tv/</a>

Live On CNBC FHFA Director Bill Pulte Says: Fannie Mae And Freddie Mac Could Be Worth Trillions of Dollars

<a href="https://x.com/pulte/status/1927362114894585944">https://x.com/pulte/status/1927362114894585944</a>

Federal Housing Finance Administration Director Bill Pulte Posts On X "Thanks for input. Still not happy with FICO. We should be making some decisions on all related items in next 1-3 weeks."

Oppenheimer analyst Owen Lau maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Outperform and raises the price target from $277 to $296.

Oppenheimer Maintains Outperform on Equifax, Raises Price Target to $296

During the last three months, 5 analysts shared their evaluations of Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>), revealing diverse outlooks from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Equifax, presenting an average target of $289.0, a high estimate of $306.00, and a low estimate of $260.00. A 5.0% drop is evident in the current average compared to the previous average price target of $304.20. 
<img src="https://www.benzinga.com/files/images/story/2025/1747854059_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Equifax. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$306.00</td>
<td>$288.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$300.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Kyle Peterson</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$295.00</td>
<td>$295.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$284.00</td>
<td>$313.00</td>
</tr>
<tr>
<td>Manav Patnaik</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$260.00</td>
<td>$325.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Equifax. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Equifax compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Equifax's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Equifax's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/EFX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Equifax analyst ratings.</a>
<h2>About Equifax</h2>
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.
<h3>Breaking Down Equifax's Financial Performance</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Equifax's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 3.79%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Equifax's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 9.23%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 2.72%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Equifax's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 1.13%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Equifax's debt-to-equity ratio is below the industry average. With a ratio of 1.0, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>How Are Analyst Ratings Determined?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Equifax

Notizie

Ultime notizie per Equifax (NYSE:EFX) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO